Research ArticleBasic Science Investigation
99mTc-HYNIC-Folate: A Novel Receptor-Based Targeted Radiopharmaceutical for Tumor Imaging
Wenjin Guo, George H. Hinkle and Robert J. Lee
Journal of Nuclear Medicine September 1999, 40 (9) 1563-1569;
Wenjin Guo
George H. Hinkle


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
99mTc-HYNIC-Folate: A Novel Receptor-Based Targeted Radiopharmaceutical for Tumor Imaging
Wenjin Guo, George H. Hinkle, Robert J. Lee
Journal of Nuclear Medicine Sep 1999, 40 (9) 1563-1569;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Development and Pre-clinical Evaluation of New 68Ga-NOTA-folate Conjugates for PET Imaging of Folate Receptor-positive Tumors
- Folic Acid Conjugates for Nuclear Imaging of Folate Receptor-Positive Cancer
- In Vivo Assay of Folate Receptors in Nonfunctional Pituitary Adenomas with 99mTc-Folate SPECT/CT
- Pemetrexed Improves Tumor Selectivity of 111In-DTPA-Folate in Mice with Folate Receptor-Positive Ovarian Cancer
- SPECT Study of Folate Receptor-Positive Malignant and Normal Tissues in Mice Using a Novel 99mTc-Radiofolate
- Synthesis and Preclinical Evaluation of a Folic Acid Derivative Labeled with 18F for PET Imaging of Folate Receptor-Positive Tumors
- Preclinical Evaluation of 99mTc-EC20 for Imaging Folate Receptor-Positive Tumors
- Evaluation of 111In-DTPA-Folate as a Receptor-Targeted Diagnostic Agent for Ovarian Cancer: Initial Clinical Results